These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37546048)

  • 21. A case report involving suppressed nuclear receptor transcription factors 4a1 and Stevens-Johnson syndrome induced by a single dose of pembrolizumab and successfully treated with early steroid administration, resulting in complete remission of stage III lung cancer.
    Machida M; Yamazaki C; Kouda N; Hanai Y; Sato H; Konda A; Yamagata Y; Itho T; Aisaka H
    J Pharm Health Care Sci; 2022 Dec; 8(1):29. PubMed ID: 36464708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of China.
    Sun J; Liu J; Gong QL; Ding GZ; Ma LW; Zhang LC; Lu Y
    Drug Des Devel Ther; 2014; 8():2539-47. PubMed ID: 25548516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Front Pharmacol; 2021; 12():750173. PubMed ID: 35115922
    [No Abstract]   [Full Text] [Related]  

  • 24. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pembrolizumab associated Stevens-Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma.
    Zhang J; Zhang P; Xu QY; Zhu YT; Chen W; Ji C
    Australas J Dermatol; 2022 Feb; 63(1):e71-e74. PubMed ID: 34463968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
    Houschyar KS; Tapking C; Borrelli MR; Puladi B; Ooms M; Wallner C; Duscher D; Pförringer D; Rein S; Reumuth G; Schulz T; Nietzschmann I; Maan ZN; Grieb G; Philipp-Dormston WG; Branski LK; Siemers F; Lehnhardt M; Schmitt L; Yazdi AS
    J Wound Care; 2021 Dec; 30(12):1012-1019. PubMed ID: 34881995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.
    Antoon JW; Goldman JL; Shah SS; Lee B
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):244-250.e1. PubMed ID: 29859332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pembrolizumab-induced autoimmune Stevens-Johnson syndrome/toxic epidermal necrolysis with myositis and myocarditis in a patient with esophagogastric junction carcinoma: a case report.
    Cao J; Li Q; Zhi X; Yang F; Zhu W; Zhou T; Hou X; Chen D
    Transl Cancer Res; 2021 Aug; 10(8):3870-3876. PubMed ID: 35116686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin rash in the intensive care unit: Stevens-Johnson syndrome, toxic epidermal necrolysis, or a rare manifestation of a hidden cutaneous malignancy: A case report.
    Al-Saffar F; Ibrahim S; Patel P; Jacob R; Palacio C; Cury J
    Mol Clin Oncol; 2016 Mar; 4(3):413-415. PubMed ID: 26998294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pembrolizumab-induced Stevens-Johnson Syndrome with Severe Ocular Complications.
    Ryu S; Jun I; Kim TI; Seo KY; Kim EK
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1533-1535. PubMed ID: 33826467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen.
    Kim EJ; Lim H; Park SY; Kim S; Yoon SY; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
    Asia Pac Allergy; 2014 Jan; 4(1):68-72. PubMed ID: 24527413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Dermatological Treatments for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan.
    Hsieh MH; Watanabe T; Aihara M
    Front Med (Lausanne); 2021; 8():636924. PubMed ID: 34395458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z
    Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature.
    Wu JY; Kang K; Yi J; Yang B
    World J Clin Cases; 2022 Jun; 10(18):6110-6118. PubMed ID: 35949835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of intravenous immunoglobulin in the treatment of stevens-johnson syndrome and toxic epidermal necrolysis.
    Momin SB
    J Clin Aesthet Dermatol; 2009 Feb; 2(2):51-8. PubMed ID: 20967183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children.
    Koh MJ; Tay YK
    J Am Acad Dermatol; 2010 Jan; 62(1):54-60. PubMed ID: 19811851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atezolizumab-Induced Stevens-Johnson Syndrome in a Patient with Non-Small Cell Lung Carcinoma.
    Chirasuthat P; Chayavichitsilp P
    Case Rep Dermatol; 2018; 10(2):198-202. PubMed ID: 30186133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.